Ocko Matthew
Insider CIK 1836089 · RXRX 10% owner · ZY Director · ABCL 10% owner · RKLB Director · EMBK 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 22,130 | $51.79 | $1.15M | 1,356,524 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 9,000 | $51.79 | $466.1K | 551,674 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 31,948 | $50.24 | $1.61M | 1,378,654 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 12,993 | $50.24 | $652.8K | 560,674 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 165,753 | $49.24 | $8.16M | 1,410,602 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 67,409 | $49.24 | $3.32M | 573,667 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 341,545 | $48.53 | $16.58M | 1,576,355 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 138,901 | $48.53 | $6.74M | 641,076 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 745,239 | $47.49 | $35.39M | 1,917,900 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 303,076 | $47.49 | $14.39M | 779,977 | SEC↗ |
| RKLB Rocket Lab Corp | J Other | 2025-09-16 | 2025-09-18 | 164,026 | — | $0 | 164,026 | SEC↗ |
| RKLB Rocket Lab Corp | J Other | 2025-09-16 | 2025-09-18 | 9,894 | — | $0 | 9,894 | SEC↗ |
| RKLB Rocket Lab Corp | J Other | 2025-09-16 | 2025-09-18 | 1,331,569 | — | $0 | 0 | SEC↗ |
| RKLB Rocket Lab Corp | J Other | 2025-09-16 | 2025-09-18 | 541,526 | — | $0 | 0 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 24,955 | $52.23 | $1.30M | 1,331,569 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-09-16 | 2025-09-18 | 10,148 | $52.23 | $530.0K | 541,526 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-06-13 | 2025-06-18 | 582,932 | $26.01 | $15.16M | 2,663,139 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-06-13 | 2025-06-18 | 237,068 | $26.01 | $6.17M | 1,083,053 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-06-12 | 2025-06-18 | 142,178 | $26.44 | $3.76M | 3,246,071 | SEC↗ |
| RKLB Rocket Lab Corp | S Sale | 2025-06-12 | 2025-06-18 | 57,822 | $26.44 | $1.53M | 1,320,121 | SEC↗ |
| RKLB Rocket Lab USA, Inc. | S Sale | 2024-11-15 | 2024-11-18 | 973,192 | $18.21 | $17.72M | 1,377,943 | SEC↗ |
| RKLB Rocket Lab USA, Inc. | S Sale | 2024-11-15 | 2024-11-18 | 2,393,001 | $18.21 | $43.58M | 3,388,249 | SEC↗ |
| RKLB Rocket Lab USA, Inc. | S Sale | 2024-11-14 | 2024-11-18 | 1,421,785 | $17.73 | $25.21M | 5,781,250 | SEC↗ |
| RKLB Rocket Lab USA, Inc. | S Sale | 2024-11-14 | 2024-11-18 | 578,215 | $17.73 | $10.25M | 2,351,135 | SEC↗ |
| ZY Zymergen Inc. | D To issuer | 2022-10-19 | 2022-10-19 | 2,448,901 | — | $0 | 0 | SEC↗ |
| ZY Zymergen Inc. | D To issuer | 2022-10-19 | 2022-10-19 | 4,917,734 | — | $0 | 0 | SEC↗ |
| EMBK Embark Technology, Inc. | P Buy | 2022-08-30 | 2022-09-01 | 10,000 | $9.64 | $96.4K | 3,212,107 | SEC↗ |
| EMBK Embark Technology, Inc. | P Buy | 2022-08-18 | 2022-08-22 | 10,000 | $11.64 | $116.4K | 3,202,107 | SEC↗ |
| EMBK Embark Technology, Inc. | P Buy | 2022-08-16 | 2022-08-18 | 122,000 | $0.84 | $102.5K | 3,192,107 | SEC↗ |
| ABCL AbCellera Biologics Inc. | J Other | 2021-06-18 | 2021-06-22 | 73,892 | — | $0 | 73,892 | SEC↗ |
| ABCL AbCellera Biologics Inc. | J Other | 2021-06-18 | 2021-06-22 | 5,000,000 | — | $0 | 24,105,761 | SEC↗ |
| ZY Zymergen Inc. | C Conversion deriv | 2021-04-26 | 2021-04-26 | 223,945 | — | $0 | 0 | SEC↗ |
| ZY Zymergen Inc. | C Conversion deriv | 2021-04-26 | 2021-04-26 | 294,401 | — | $0 | 0 | SEC↗ |
| ZY Zymergen Inc. | C Conversion deriv | 2021-04-26 | 2021-04-26 | 1,684,397 | — | $0 | 0 | SEC↗ |
| ZY Zymergen Inc. | C Conversion deriv | 2021-04-26 | 2021-04-26 | 210,450 | — | $0 | 0 | SEC↗ |
| ZY Zymergen Inc. | C Conversion deriv | 2021-04-26 | 2021-04-26 | 2,014,506 | — | $0 | 0 | SEC↗ |
| ZY Zymergen Inc. | C Conversion deriv | 2021-04-26 | 2021-04-26 | 2,936,283 | — | $0 | 0 | SEC↗ |
| ZY Zymergen Inc. | C Conversion | 2021-04-26 | 2021-04-26 | 1,687,050 | — | $0 | 4,623,333 | SEC↗ |
| ZY Zymergen Inc. | C Conversion | 2021-04-26 | 2021-04-26 | 2,014,506 | — | $0 | 2,224,956 | SEC↗ |
| ZY Zymergen Inc. | C Conversion | 2021-04-26 | 2021-04-26 | 223,945 | — | $0 | 2,448,901 | SEC↗ |
| ZY Zymergen Inc. | C Conversion | 2021-04-26 | 2021-04-26 | 210,450 | — | $0 | 210,450 | SEC↗ |
| ZY Zymergen Inc. | C Conversion | 2021-04-26 | 2021-04-26 | 294,401 | — | $0 | 4,917,734 | SEC↗ |
| ZY Zymergen Inc. | C Conversion | 2021-04-26 | 2021-04-26 | 2,936,283 | — | $0 | 2,936,283 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 3,726,963 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 1,095,529 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 730,353 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 3,771,996 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 1,073,595 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 3,220,788 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 3,726,963 | — | $0 | 3,726,963 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 3,726,963 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 3,726,963 | — | $0 | 3,726,963 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 3,951,141 | — | $0 | 3,951,141 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 3,951,141 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 3,951,141 | — | $0 | 3,951,141 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 5,941,120 | — | $0 | 5,941,120 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 5,941,120 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 5,941,120 | — | $0 | 5,941,120 | SEC↗ |
| ABCL AbCellera Biologics Inc. | C Conversion deriv | 2020-12-15 | 2020-12-17 | 2,105,264 | — | $0 | 0 | SEC↗ |
| ABCL AbCellera Biologics Inc. | C Conversion deriv | 2020-12-15 | 2020-12-17 | 802,371 | — | $0 | 0 | SEC↗ |
| ABCL AbCellera Biologics Inc. | C Conversion deriv | 2020-12-15 | 2020-12-17 | 0 | — | $0 | 0 | SEC↗ |
| ABCL AbCellera Biologics Inc. | C Conversion | 2020-12-15 | 2020-12-17 | 29,411 | — | $0 | 29,105,761 | SEC↗ |
| ABCL AbCellera Biologics Inc. | C Conversion | 2020-12-15 | 2020-12-17 | 29,076,350 | — | $0 | 29,076,350 | SEC↗ |